Obesity, as a global chronic disease characterized by excessive fat accumulation, affects the health of approximately 650 million people and is associated with an increased risk of multiple metabolic complications, such as Type 2 diabetes and non-alcoholic fatty liver disease, as well as cardiovascular diseases and mechanical issues, including osteoarthritis and obstructive sleep apnea
Curcumin as Add-On to antipsychotic treatment in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
Oral Semaglutide (Rybelsus): Achieves around a 1.5% A1c reduction and 4.4 kg weight loss but requires precise fasting and water-intake conditions
Brand: Rayju (Premium Thai Beauty Wellness Brand)
Professional clinics use only hospital-grade ingredients and equipment to ensure the safety of their patients
The drug was originally approved for adults with obesity in June 2021